• Policy
• Moderna will only supply Spikevax Duo 2 in Korea
• by Lee, Hye-Kyung Jan 18, 2024 06:07am

• Company
• MA manager files complaint on NHIS official's abuse of power
• by Eo, Yun-Ho Jan 18, 2024 06:07am

• Policy
• Drug price cuts will be applied in bulk next month
• by Lee, Tak-Sun Jan 18, 2024 06:07am

• Policy
• Stability data requirement eased for metformin approvals
• by Lee, Hye-Kyung Jan 17, 2024 05:29am

• Company
• Orion bids KRW 548.5 bil to enter the pharma industry
• by Kim, Jin-Gu Jan 17, 2024 05:29am

• Company
• KRPIA's new BOD is full of Korean members
• by Eo, Yun-Ho Jan 17, 2024 05:29am

• Policy
• High-priced drugs receive reimb in the new year
• by Lee, Tak-Sun Jan 17, 2024 05:29am

• Company
• Whan In has exclusive distribution rights for Sanofi's Arava
• by Kim, Jin-Gu Jan 16, 2024 06:09am

• Policy
• Caution required for use of ADHD drug methylphenidate
• by Lee, Hye-Kyung Jan 16, 2024 06:09am

• Company
• Gov't will reduce fines for companies that adopt CPs
• by Kang, Shin-Kook Jan 16, 2024 06:08am